Lebenthal Holdings’s Pfizer PFE Stock Holding History

Lebenthal Holdings’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$6.97M	Sell	208,614 -3,012	-1%	-$96.1K	0.86%	25
2016 Q1	$5.95M	Buy	211,626 +23,274	+12%	+$665K	1.04%	9
2015 Q4	$5.77M	Buy	188,352 +29	+0%	+$912	1.35%	5
2015 Q3	$5.61M	Sell	188,323 -11,040	-6%	-$354K	1.29%	4
2015 Q2	$6.36M	Sell	199,363 -13,892	-7%	-$453K	1.3%	4
2015 Q1	$7.04M	Buy	213,255 +22,839	+12%	+$726K	1.65%	2
2014 Q4	$5.63M	Buy	+190,416	New	+$5.46M	2.48%	3

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lebenthal Holdings's PFE Position: Q2 2016 in Review

Lebenthal Holdings reduced its Pfizer (PFE) stake by 1.4% in Q2 2016, selling an estimated $96.1K and leaving 208,614 shares worth $6.97M. The position accounts for 0.86% of the portfolio, ranked #25.

Lebenthal Holdings first reported a position in PFE in Q4 2014 and has held it in 7 quarters since. The position peaked at $7.04M in Q1 2015. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Lebenthal Holdings held 208,614 shares of Pfizer worth $6.97M as of Q2 2016.
Lebenthal Holdings sold 3,012 Pfizer shares in Q2 2016, an estimated $96.1K.
Pfizer made up 0.86% of Lebenthal Holdings's portfolio in Q2 2016, its #25 holding.
Lebenthal Holdings first reported a position in Pfizer in Q4 2014 and has held it in 7 quarters since.
Lebenthal Holdings's Pfizer position peaked at $7.04M in Q1 2015.
1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.